AAAAAA
Results: 1-25/40
Authors:
Walewski, J
Kraszewska, E
Mioduszewska, O
Romejko-Jarosinska, J
Hellmann, A
Czyz, J
Holowiecki, J
Kopera, M
Grosicki, S
Komarnicki, M
Rumianowski, L
Kuliczkowski, K
Wrobel, T
Dwilewicz-Trojaczek, J
Robak, T
Warzocha, K
Zaluski, J
Wojcik, E
Dmoszynska, A
Walter-Croneck, A
Citation: J. Walewski et al., Rituximab (Mabthera (TM), Rituxan (TM)) in patients with recurrent indolent lymphoma - Evaluation of safety and efficacy in a multicenter study, MED ONCOL, 18(2), 2001, pp. 141-148
Authors:
Robak, T
Kasznicki, M
Bartkowiak, J
Kordek, R
Wawrzyniak, E
Blonski, JZ
Citation: T. Robak et al., Richter's syndrome following cladribine therapy for chronic lymphocytic leukemia first manifested as pathologic fracture of the femur, LEUK LYMPH, 42(4), 2001, pp. 789
Authors:
Robak, T
Blonski, JZ
Kasznicki, M
Citation: T. Robak et al., Does intensive treatment with high dose chlorambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia?, LEUK LYMPH, 41(5-6), 2001, pp. 545-557
Authors:
Kilianska, ZM
Chrusciel, J
Niewiadomska, H
Blonski, J
Rogalinska, M
Blaszczyk, A
Robak, T
Citation: Zm. Kilianska et al., Altered expression of nuclear non-histone protein (P44/46) in different stages of B-chronic lymphocytic leukemia, LEUK LYMPH, 41(5-6), 2001, pp. 635-642
Authors:
Robak, T
Robak, E
Bartkowiak, J
Blonski, JZ
Niewiadomska, H
Wawrzyniak, E
Citation: T. Robak et al., Low-grade non-Hodgkin's lymphoma in a patient with systemic lupus erythematosus, LEUK LYMPH, 41(5-6), 2001, pp. 659
Authors:
Robak, T
Citation: T. Robak, Cladribine in the treatment of chronic lymphocytic leukemia, LEUK LYMPH, 40(5-6), 2001, pp. 551-564
Authors:
Robak, E
Niewiadomska, H
Robak, T
Bartkowiak, J
Blonski, JZ
Wozniacka, A
Pomorski, L
Sysa-Jedrzejowska, A
Citation: E. Robak et al., Lymphocytes T gamma delta in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity, MEDIAT INFL, 10(4), 2001, pp. 179-189
Authors:
Robak, T
Gora-Tybor, J
Lech-Maranda, E
Blonski, JZ
Robak, T
Citation: T. Robak et al., Cladribine in combination with mitoxantrone and cyclophosphamide (CMC) in the treatment of heavily pre-treated patients with advanced indolent lymphoid malignancies, EUR J HAEMA, 66(3), 2001, pp. 188-194
Authors:
Robak, T
Blonski, JZ
Kasznicki, M
Gora-Tybor, J
Dwilewicz-Trojaczek, J
Boguradzki, P
Konopka, L
Ceglarek, B
Sulek, J
Kuliczkowski, K
Wolowiec, D
Stella-Holowiecka, B
Skotnicki, AB
Nowak, W
Moskwa-Sroka, B
Dmoszynska, A
Calbecka, M
Citation: T. Robak et al., Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemia, LEUKEMIA, 15(10), 2001, pp. 1510-1516
Authors:
Robak, T
Gora-Tybor, J
Citation: T. Robak et J. Gora-tybor, Cladribine combined with mitoxantrone in the treatment of blastic phase ofchronic myeloid leukemia, NEOPLASMA, 48(3), 2001, pp. 203-207
Authors:
Robak, T
Kasznicki, M
Blonski, JZ
Dmoszynska, A
Skotnicki, AB
Citation: T. Robak et al., Pure red cell aplasia in patients with chronic lymphocytic leukaemia treated with cladribine, BR J HAEM, 112(4), 2001, pp. 1083-1085
Authors:
Urbanska-Rys, H
Wierzbowska, A
Stepien, H
Robak, T
Citation: H. Urbanska-rys et al., Relationship between circulating interleukin-10 (IL-10) with interleukin-6(IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 receptor (sIL-6R) in patients with multiple myeloma, EUR CYTOKIN, 11(3), 2000, pp. 443-451
Authors:
Smolewski, P
Robak, T
Krykowski, E
Blasinska-Morawiec, M
Niewiedomska, H
Pluzanska, A
Chmielowska, E
Zambrano, O
Citation: P. Smolewski et al., Prognostic factors in Hodgkin's disease: multivariate analysis of 327 patients from a single institution. (vol 6, pg 1150, 2000), CLIN CANC R, 6(5), 2000, pp. 2120-2120
Authors:
Smolewski, P
Robak, T
Krykowski, E
Blasinska-Morawiec, M
Niewiadomska, H
Pluzanska, A
Chmielowska, E
Zambrano, O
Citation: P. Smolewski et al., Prognostic factors in Hodgkin's disease: Multivariate analysis of 327 patients from a single institution, CLIN CANC R, 6(3), 2000, pp. 1150-1160
Authors:
Robak, T
Wrzesien-Kus, A
Lech-Maranda, E
Kowal, M
Dmoszynska, A
Citation: T. Robak et al., Combination regimen of cladribine (2-chlorodeoxyadenosine), cytarabine andG-CSF (CLAG) as induction therapy for patients with relapsed or refractoryacute myeloid leukemia, LEUK LYMPH, 39(1-2), 2000, pp. 121-129
Authors:
Smolewski, P
Niewiadomska, H
Los, E
Robak, T
Citation: P. Smolewski et al., Spontaneous apoptosis of Reed-Sternberg and Hodgkin cells; clinical and pathological implications in patients with Hodgkin's disease, INT J ONCOL, 17(3), 2000, pp. 603-609
Authors:
Lech-Maranda, E
Korycka, A
Robak, T
Citation: E. Lech-maranda et al., Influence of gemcitabine (2 ',2 '-difluorodeoxycytidine) and 2-chlorodeoxyadenosine on growth of normal and leukemic cells in vitro, EUR J HAEMA, 65(5), 2000, pp. 317-321
Authors:
Korycka, A
Robak, T
Citation: A. Korycka et T. Robak, Amifostine and 2-CdA: a novel purging strategy in CML autografting?, EUR J HAEMA, 64(5), 2000, pp. 347-349
Authors:
Lech-Maranda, E
Korycka, A
Robak, T
Citation: E. Lech-maranda et al., The interaction of gemcitabine and cytarabine on murine leukemias L1210 orP388 and on human normal and leukemic cell growth in vitro, HAEMATOLOG, 85(6), 2000, pp. 588-594
Authors:
Robak, T
Gora-Tybor, J
Chojnowski, K
Citation: T. Robak et al., Cladribine as monotherapy or combined with dexamethasone and idarubicin ormitoxantrone in previously treated patients with low-grade lymphoid malignancies, HAEMATOLOG, 85(2), 2000, pp. 215-216
Authors:
Mucha, S
Zylinska, K
Pisarek, H
Komorowski, J
Robak, T
Korycka, A
Stepien, H
Citation: S. Mucha et al., Pituitary-adrenocortical responses to the chronic administration of granulocyte colony-stimulating factor in rats, J NEUROIMM, 102(1), 2000, pp. 73-78
Authors:
Robak, T
Szmigielska, A
Citation: T. Robak et A. Szmigielska, Dexamethasone does not enhance antileukemic activity of cladribine in micewith leukemias L1210 and P388, NEOPLASMA, 47(3), 2000, pp. 168-171
Authors:
Robak, T
Blonski, JZ
Kasznicki, M
Konopka, L
Ceglarek, B
Dmoszynska, A
Soroka-Wojtaszko, M
Skotnicki, AB
Nowak, W
Dwilewicz-Trojaczek, J
Tomaszewska, A
Hellmann, A
Lewandowski, K
Kuliczkowski, K
Potoczek, S
Zdziarska, B
Hansz, J
Kroll, R
Komarnicki, M
Holowiecki, J
Grieb, P
Citation: T. Robak et al., Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients, BR J HAEM, 108(2), 2000, pp. 357-368
Authors:
Robak, T
Blonski, JZ
Kasznicki, M
Blasinska-Morawiec, M
Krykowski, E
Dmoszynska, A
Mrugala-Spiewak, H
Skotnicki, AB
Nowak, W
Konopka, L
Ceglarek, B
Maj, S
Dwilewicz-Trojaczek, J
Hellmann, A
Urasinski, I
Zdziarska, B
Kotlarek-Haus, S
Potoczek, S
Grieb, P
Citation: T. Robak et al., Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial, BLOOD, 96(8), 2000, pp. 2623-2629
Authors:
Robak, T
Blonski, JZ
Kasznicki, M
Blasinska-Morawiec, M
Krykowski, E
Dmoszynska, A
Mrugala-Spiewak, H
Skotnicki, AB
Nowak, W
Konopka, L
Ceglarek, B
Maj, S
Dwilewicz-Trojaczek, J
Heilmann, A
Urasinski, I
Zdziarska, B
Kotlarek-Haus, S
Potoczek, S
Grieb, P
Citation: T. Robak et al., Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial, BLOOD, 96(8), 2000, pp. 2723-2729